EMBL Ventures is an independent venture capital investor that manages two Funds with a total of €68 million capital on behalf of major European institutional and private investors. EMBL Ventures' close relationship with the European Molecular Biology Laboratory (EMBL) and its technology transfer organization EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) allows it to finance disruptive technologies in an entrepreneurial start-up environment, aiming ultimately for a transaction with a partner that is seeking to acquire external product innovation. EMBL Ventures is exclusively focused on life-science investments.

"From the very beginning, EMBL Ventures's enthusiasm for our technology has been palpable. Their strong interest in novel drug development, combined with a clear understanding of its complexity and a definite commitment, makes EMBL Ventures a unique and strong value-adding investor that we would certainly recommend to any start-up company. They are really active investors in the true sense of the word. Their guidance and support was always instrumental, especially in successfully managing critical and difficult company transitions."
Christian Wandersee; CEO, Vasopharm, Würzburg